Today, the Alliance for Integrity and Reform of 340B (AIR340B) released a new poll conducted by Morning Consult that found a majority of those surveyed agreed the 340B Drug Pricing Program needs fixes to better serve the most vulnerable patients.

“The findings from this new poll are a stark reminder of the work we must do to save the 340B program – most importantly, to support the vulnerable and low-income communities that rely on it to help them access their medications. Through greater transparency, accountability, and oversight of the program, we can get 340B back on track so it fully benefits patients,” said former Illinois Congressman and AIR340B Spokesman Bob Dold.

AIR340B’s comments and recommendations are chiefly concerned with identifying areas in which the program can be improved to achieve its purpose – to increase access to discounted medicines to safety-net providers who treat needy patients. This includes clearly defining the eligibility of a 340B patient and addressing 340B-driven hospital consolidation, restricting contract pharmacy arrangements, and establishing clear reporting requirements for disproportionate share (DSH) hospitals.